jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 20, 2009

Dec. 17, 2018

jRCT2080220721

Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa

Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa

version:
date:

R-tech Ueno, Ltd

http://www.rtechueno.com/contact_jp.php

105

Interventional

Multicenter, randomized, double-blind, parallel-three groups study

2

Decimal visual acuity: 0.5 or better
With abnormal visual field measured by the Goldmann perimetry

The subject has taken steroids and/or vasodilators within 1 month prior to informed consent.

20age old over
65age old under

Both

retinitis pigmentosa

investigational material(s)
Generic name etc : UF-021 (isopropyl unoprostone)
INN of investigational material :
Therapeutic category code : 131 Agents for ophthalmic use
Dosage and Administration for Investigational material : Eye drop

Efficacy and safety

R-Tech Ueno, Ltd

JapicCTI-090748

History of Changes

No Publication date
8 Dec. 17, 2018 (this page) Changes
7 Feb. 27, 2013 Detail Changes
6 Feb. 27, 2013 Detail Changes
5 Aug. 10, 2010 Detail Changes
4 Aug. 10, 2010 Detail Changes
3 Aug. 27, 2009 Detail Changes
2 April. 20, 2009 Detail Changes
1 April. 20, 2009 Detail